Granules India added 1.77% to Rs 673.95 after the US Food and Drug Administration (FDA) approved its abbreviated new drug application (ANDA) for Glycopyrrolate Oral Solution.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
